Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

The following seven companies represent the vanguard of this movement, driving the industry's technical and strategic evolution.

Cancer tumorigenesis is fundamentally driven by the profound dysregulation of gene regulatory networks (GRNs) and complex epigenetic alterations. With the ...

Jonathan D. Uslaner and Matthew Goldstein of Bernstein Litowitz Berger & Grossmann LLP examine the proposed new Federal Rule ...

Applications have been invited for admission to Undergraduate Programme [B.Sc. (Hons.) in Mathematics and Computing]; ...

A misconception is currently thriving in the industry that one can become a Generative AI expert without learning ...

Artificial intelligence in education is only as good as the curriculum that decides whether it supports thought or replaces ...

Artificial Intelligence has emerged as a fundamental technology that underpins contemporary digital systems across sectors ...

The Urology Care Foundation (UCF), the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association (AUA), is pleased to announce the ...

Artificial intelligence is reshaping economies worldwide, and Pakistan is building momentum through startups and universities. But limited R&D, digital infrastructure gaps, and job disruption risks ...